Vydate 10G

Primær information

  • Handelsnavn:
  • Vydate 10G Granulat
  • Lægemiddelform:
  • Granulat
  • Sammensætning:
  • 100 g/kg oxamyl
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

Lokation

  • Fås i:
  • Vydate 10G Granulat
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Udgået
  • Sidste ændring:
  • 08-02-2018

Produktresumé

SAFETY DATA SHEET

according to EC directive 2001/58/EC

VYDATE

®

10 G

Version 2.1

Revision Date 09.07.2004

Ref. 130000000049

This SDS adheres to the standards and regulatory requirements of Great Britain and may not meet the regulatory

requirements in other countries.

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING

Product information

Product name

VYDATE

10 G

Synonyms

B10049174

Use of the

Substance/Preparation

insecticide

Company

Du Pont (U.K.) Limited

Wedgwood Way

SG1 4QN Stevenage

+4401438734450

Telefax

Emergency telephone

number

+44-(0)2871-861.313

2. COMPOSITION/INFORMATION ON INGREDIENTS

Chemical Name

CAS-No.

EC-No.

Classification

Concentration [%]

Oxamyl

23135-22-0

T+; R26/28

Xn; R21

N; R51

CYCLOHEXANONE

108-94-1

203-631-1

Xn; R20

5 - 7

Phosphoric acid

7664-38-2

231-633-2

C; R34

3 - 4,5

For the full text of the R phrases mentioned in this Section, see Section 16.

3. HAZARDS IDENTIFICATION

Toxic by inhalation and if swallowed.

Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.

4. FIRST AID MEASURES

General advice

Call a physician or Poison Control Centre immediately. This product contains an

anticholinesterase compound. Do not use if under medical advice not to work

with such compounds. Never give anything by mouth to an unconscious person.

If breathing is irregular or stopped, administer artificial respiration. For specialist

advice physicians should contact the National Poisons Information Service, (24-

hr), Tel: 0870-600-6266.

Inhalation

Move to fresh air. If victim is unconscious but breathing: Give oxygen.

Skin contact

Wash off immediately with soap and plenty of water. Take off contaminated

Print date: 2005 - 2 - 10

SAFETY DATA SHEET

according to EC directive 2001/58/EC

VYDATE

®

10 G

Version 2.1

Revision Date 09.07.2004

Ref. 130000000049

clothing and shoes immediately. If skin irritation persists, call a physician.

Eye contact

Rinse thoroughly with plenty of water, also under the eyelids. Keep eye wide

open while rinsing. If eye irritation persists, consult a specialist.

Ingestion

Drink 1 or 2 glasses of water. Do not induce vomiting without medical advice.

Notes to physician

Symptoms

constriction of pupils, blurred vision, Daze, Breathing difficulties, sweating, slow

pulse, muscle twitching, weakness, headache

Risks

This product is a cholinesterase inhibitor carbamate.

Treatment

Administer atropine sulphate as antidote. bis zur völligen Atropisierung

Morphine, 2-PAM and oxime therapy are contra-indicated.

5. FIRE-FIGHTING MEASURES

Suitable extinguishing

media

water spray, foam, dry chemical, carbon dioxide (CO2),

Extinguishing media which

must not be used for safety

reasons

high volume water jet, (contamination risk),

Special protective

equipment for fire-fighters

In the event of fire, wear self-contained breathing apparatus.

Further information

(on small fires) If area is heavily exposed to fire and if conditions permit, let fire

burn itself out since water may increase the area contaminated. Cool containers

/ tanks with spray water.

6. ACCIDENTAL RELEASE MEASURES

Personal precautions

Wear personal protective equipment.

Environmental precautions

Do not flush into surface water or sanitary sewer system. Do not allow material

to contaminate ground water system. Do not contaminate surface water.

Methods for cleaning up

Clean up promptly by scoop or vacuum. Use approved industrial vacuum

cleaner for removal. Small amounts: Clean up promptly by sweeping or vacuum.

7. HANDLING AND STORAGE

Handling

Advice on safe handling

Provide appropriate exhaust ventilation at places where dust is formed. In case

of insufficient ventilation, wear suitable respiratory equipment. Wear personal

protective equipment. Avoid dust formation in confined areas.

Advice on protection

against fire and explosion

Keep away from heat and sources of ignition.

Print date: 2005 - 2 - 10

SAFETY DATA SHEET

according to EC directive 2001/58/EC

VYDATE

®

10 G

Version 2.1

Revision Date 09.07.2004

Ref. 130000000049

Storage

Requirements for storage

areas and containers

Keep containers tightly closed in a dry, cool and well-ventilated place. Store in a

place accessible by authorized persons only. Keep out of the reach of children.

Advice on common storage

No materials to be specially mentioned.

8. EXPOSURE CONTROLS / PERSONAL PROTECTION

Components with workplace control parameters

Components

CAS-No.

Type

Control

parameters

Update

Basis

CYCLOHEXANONE

108-94-1

STEL

TWA (8 & 12 hr)

TWA (STEL 15

min)

102 mg/m3

408 mg/m3

2001

2001

EH40 OES

EH40 OES

DUPONT

DUPONT

Engineering measures

Ensure adequate ventilation, especially in confined areas.

Personal protective equipment

Respiratory protection

Respirator with combination filter for vapour/particulate.

Hand protection

Material: nitrile rubber

Glove thickness: 0,4 - 0,7 mm

Wearing time: 480 min

Please observe the instructions regarding permeability and breakthrough time

which are provided by the supplier of the gloves. Also take into consideration the

specific local conditions under which the product is used, such as the danger of

cuts, abrasion, and the contact time.

Eye protection

face-shield tightly fitting safety goggles

Skin and body protection

complete suit protecting against chemicals

Hygiene measures

Wash hands before breaks and immediately after handling the product. Keep

away from food, drink and animal feedingstuffs. When using, do not eat, drink or

smoke. Do not breathe dust. Avoid contact with skin, eyes and clothing.

Protective measures

Do not breathe dust. All chemical protective clothing should be visually

inspected prior to use. Clothing and gloves should be replaced in case of

chemical or physical damage or if contaminated.

9. PHYSICAL AND CHEMICAL PROPERTIES

Form

solid, granular,

Print date: 2005 - 2 - 10

SAFETY DATA SHEET

according to EC directive 2001/58/EC

VYDATE

®

10 G

Version 2.1

Revision Date 09.07.2004

Ref. 130000000049

Colour

blue green,

Odour

slight, solvent,

6,8 at 100 g/l ( 24 °C)

Flash point

not applicable

Explosive properties

Not explosive

Bulk density

720 kg/m3

Water solubility

229 g/l at 25 °C

10. STABILITY AND REACTIVITY

Hazardous decomposition

products

: Carbon oxides, nitrogen oxides (NOx)

Hazardous reactions

: Dust may form explosive mixture in air. No decomposition if stored and applied

as directed.

11. TOXICOLOGICAL INFORMATION

Acute oral toxicity

LD50/rat male: 43 mg/kg

LD50/rat female: 34 mg/kg

Acute inhalation toxicity

LC50/4 h/rat : 0,68 mg/l

Acute dermal toxicity

LD50/rabbit : > 5 000 mg/kg

Skin irritation

rabbit

No skin irritation

Skin irritation

CYCLOHEXANONE

rabbit

Result: No skin irritation Method: OECD Test Guideline 404

Eye irritation

rabbit

No eye irritation

Eye irritation

CYCLOHEXANONE

rabbit

Result: Moderate eye irritation

Sensitization

guinea pig Did not cause sensitization on laboratory animals.

Sensitization

Print date: 2005 - 2 - 10

SAFETY DATA SHEET

according to EC directive 2001/58/EC

VYDATE

®

10 G

Version 2.1

Revision Date 09.07.2004

Ref. 130000000049

CYCLOHEXANONE

guinea pig Result: Animal test did not cause sensitization by skin contact.

Repeated dose toxicity

CYCLOHEXANONE

Oral rat, Exposure time: 175 d, NOEL: 300 mg/kg

12. ECOLOGICAL INFORMATION

Elimination information (persistence and degradability)

Biodegradability

According to the results of tests of biodegradability this product is considered as

being readily biodegradable.

Ecotoxicity effects

Toxicity to fish

LC50/96 h/Rainbow trout: 36 mg/l

LC50/96 h/Bluegill sunfish: 47 mg/l

Toxicity to fish

CYCLOHEXANONE

LC50/96 h/Fathead minnow: 527 mg/l

Toxicity to algae

EC50/72 h/selenastrum capricornutum: 31 mg/l

Aquatic toxicity

EC50/48 h/Daphnia: 3,3 mg/l

Aquatic toxicity

CYCLOHEXANONE

EC50/24 h/Daphnia: 800 mg/l

13. DISPOSAL CONSIDERATIONS

Product

In accordance with local and national regulations. Must be incinerated in a

suitable incineration plant holding a permit delivered by the competent

authorities. Do not contaminate ponds, waterways or ditches with chemical or

used container.

Contaminated packaging

Do not re-use empty containers.

14. TRANSPORT INFORMATION

ADR

Class:

Packaging group:

Print date: 2005 - 2 - 10

SAFETY DATA SHEET

according to EC directive 2001/58/EC

VYDATE

®

10 G

Version 2.1

Revision Date 09.07.2004

Ref. 130000000049

Classification Code:

HI No::

UN-No:

2757

Labelling No.:

Proper shipping name:

CARBAMATE PESTICIDE, SOLID, TOXIC (Oxamyl)

IATA_C

Class:

Packaging group:

UN-No:

2757

Labelling No.:

Proper shipping name:

Carbamate pesticide, solid, toxic (contains Oxamyl)

IMDG

Class:

Packaging group:

UN-No:

2757

Labelling No.:

Proper shipping name:

CARBAMATE PESTICIDE, SOLID, TOXIC (contains Oxamyl)

Marine pollutant:

Marine pollutant.

15. REGULATORY INFORMATION

Labelling according to EEC Directive

Symbol(s)

Toxic

Dangerous for the environment

Hazardous components:

Oxamyl

R-phrase(s)

R23/25

Toxic by inhalation and if swallowed.

R51/53

Toxic to aquatic organisms, may cause long-term adverse

effects in the aquatic environment.

S-phrase(s)

Keep out of reach of children.

Keep away from food, drink and animal feedingstuffs.

S20/21

When using, do not eat, drink or smoke.

This material and its container must be disposed of in a safe

way.

In case of insufficient ventilation, wear suitable respiratory

equipment.

In case of accident or if you feel unwell, seek medical advice

immediately (show label where possible).

Use appropriate containment to avoid environmental

contamination.

Exceptional labelling of

special preparations

To avoid risks to man and the environment, comply with the instructions for use.

Print date: 2005 - 2 - 10

SAFETY DATA SHEET

according to EC directive 2001/58/EC

VYDATE

®

10 G

Version 2.1

Revision Date 09.07.2004

Ref. 130000000049

16. OTHER INFORMATION

Text of R phrases mentioned in Section 2

Flammable.

Harmful by inhalation.

Harmful in contact with skin.

R26/28

Also very toxic by inhalation and if swallowed.

Causes burns.

Toxic to aquatic organisms.

May cause long-term adverse effects in the aquatic environment.

The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at

the date of its publication. The information given is designed only as a guidance for safe handling, use, processing,

storage, transportation, disposal and release and is not to be considered a warranty or quality specification. The

information relates only to the specific material designated and may not be valid for such material used in

combination with any other materials or in any process, unless specified in the text.

Print date: 2005 - 2 - 10

  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.



  • Dokumenter på andre sprog er tilgængelige her

18-7-2018

Orphan designation:  Recombinant humanised anti-human interleukin-1 beta monoclonal antibody,  for the: Treatment of Behçet’s disease

Orphan designation: Recombinant humanised anti-human interleukin-1 beta monoclonal antibody, for the: Treatment of Behçet’s disease

On 1 October 2010, orphan designation (EU/3/10/796) was granted by the European Commission to XOMA Ireland Ltd, Ireland, for recombinant humanised anti-human interleukin-1 beta monoclonal antibody for the treatment of Behçet’s disease.

Europe - EMA - European Medicines Agency

12-7-2018

July 10, 2018: Pawtucket Woman Sentenced for Participation in Opioid Prescription Conspiracy

July 10, 2018: Pawtucket Woman Sentenced for Participation in Opioid Prescription Conspiracy

July 10, 2018: Pawtucket Woman Sentenced for Participation in Opioid Prescription Conspiracy

FDA - U.S. Food and Drug Administration

11-7-2018

July 10, 2018: VA Medical Center Nurse Indicted, Arraigned for Allegedly Tampering with and Stealing Prescription Opioids

July 10, 2018: VA Medical Center Nurse Indicted, Arraigned for Allegedly Tampering with and Stealing Prescription Opioids

July 10, 2018: VA Medical Center Nurse Indicted, Arraigned for Allegedly Tampering with and Stealing Prescription Opioids

FDA - U.S. Food and Drug Administration

11-7-2018

July 10, 2018: Former Des Moines Pharmacy Technician Sentenced for Illegally Tampering with Fentanyl

July 10, 2018: Former Des Moines Pharmacy Technician Sentenced for Illegally Tampering with Fentanyl

July 10, 2018: Former Des Moines Pharmacy Technician Sentenced for Illegally Tampering with Fentanyl

FDA - U.S. Food and Drug Administration

11-7-2018

July 10: 2018: Former Pharmacy Technician Indicted for Stealing Fentanyl, Morphine

July 10: 2018: Former Pharmacy Technician Indicted for Stealing Fentanyl, Morphine

July 10: 2018: Former Pharmacy Technician Indicted for Stealing Fentanyl, Morphine

FDA - U.S. Food and Drug Administration

6-6-2018

January 10, 2018: Six Charged in Complex Fraud Involving Fraudulent Processing of Credit Card Payments

January 10, 2018: Six Charged in Complex Fraud Involving Fraudulent Processing of Credit Card Payments

January 10, 2018: Six Charged in Complex Fraud Involving Fraudulent Processing of Credit Card Payments

FDA - U.S. Food and Drug Administration

25-5-2018

H-E-B Voluntarily Issues a Precautionary Recall H-E-B Ode to Olives Sliced Salad Olives Being Recalled for Potential Glass in The Product

H-E-B Voluntarily Issues a Precautionary Recall H-E-B Ode to Olives Sliced Salad Olives Being Recalled for Potential Glass in The Product

Committed to the quality of its products, H-E-B is voluntarily issuing an all-store precautionary recall for H-E-B Ode to Olives Sliced Salad Olives in 10-ounce glass jars with a best by date of Nov. 3, 2019 due to the possible presence of glass in the product.

FDA - U.S. Food and Drug Administration

10-7-2018

Tegsedi (IONIS USA Limited)

Tegsedi (IONIS USA Limited)

Tegsedi (Active substance: inotersen) - Centralised - Authorisation - Commission Decision (2018)4458 of Tue, 10 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4782

Europe -DG Health and Food Safety

10-7-2018

Ninlaro (Takeda Pharma A/S)

Ninlaro (Takeda Pharma A/S)

Ninlaro (Active substance: ixazomib) - Centralised - Yearly update - Commission Decision (2018)4463 of Tue, 10 Jul 2018

Europe -DG Health and Food Safety

10-7-2018

DepoCyte (Pacira Limited)

DepoCyte (Pacira Limited)

DepoCyte (Active substance: Cytarabine) - Centralised - Withdrawal - Commission Decision (2018)4490 of Tue, 10 Jul 2018

Europe -DG Health and Food Safety

10-7-2018

Fertavid (Merck Sharp and Dohme B.V.)

Fertavid (Merck Sharp and Dohme B.V.)

Fertavid (Active substance: follitropin beta) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)4474 of Tue, 10 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/1042/T/39

Europe -DG Health and Food Safety

10-7-2018

Corbilta (Orion Corporation)

Corbilta (Orion Corporation)

Corbilta (Active substance: levodopa / carbidopa / entacapone) - Centralised - Renewal - Commission Decision (2018)4468 of Tue, 10 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2785/R/15

Europe -DG Health and Food Safety

10-7-2018

Verkazia (Santen Oy)

Verkazia (Santen Oy)

Verkazia (Active substance: ciclosporin) - Centralised - Authorisation - Commission Decision (2018)4469 of Tue, 10 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4411

Europe -DG Health and Food Safety

10-7-2018

Noxafil (Merck Sharp and Dohme B.V.)

Noxafil (Merck Sharp and Dohme B.V.)

Noxafil (Active substance: Posaconazole) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)4476 of Tue, 10 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/610/T/54

Europe -DG Health and Food Safety

10-7-2018

Adrovance (Merck Sharp and Dohme B.V.)

Adrovance (Merck Sharp and Dohme B.V.)

Adrovance (Active substance: Alendronate sodium / Colecalciferol) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)4477 of Tue, 10 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/759/T/39

Europe -DG Health and Food Safety

10-7-2018

Sovaldi (Gilead Sciences Ireland UC)

Sovaldi (Gilead Sciences Ireland UC)

Sovaldi (Active substance: sofosbuvir) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)4482 of Tue, 10 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2798/T/51

Europe -DG Health and Food Safety

10-7-2018

Revolade (Novartis Europharm Limited)

Revolade (Novartis Europharm Limited)

Revolade (Active substance: Eltrombopag) - PSUSA - Modification - Commission Decision (2018)4487 of Tue, 10 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/1205/201709

Europe -DG Health and Food Safety

10-7-2018

Temozolomide HEXAL (Hexal AG)

Temozolomide HEXAL (Hexal AG)

Temozolomide HEXAL (Active substance: temozolomide) - Centralised - Yearly update - Commission Decision (2018) 4481 of Tue, 10 Jul 2018

Europe -DG Health and Food Safety

10-7-2018

Temozolomide Sandoz (Sandoz GmbH)

Temozolomide Sandoz (Sandoz GmbH)

Temozolomide Sandoz (Active substance: temozolomide) - Centralised - Yearly update - Commission Decision (2018)4480 of Tue, 10 Jul 2018

Europe -DG Health and Food Safety

10-7-2018

Pemetrexed Sandoz (Sandoz GmbH)

Pemetrexed Sandoz (Sandoz GmbH)

Pemetrexed Sandoz (Active substance: pemetrexed) - Centralised - Yearly update - Commission Decision (2018)4485 of Tue, 10 Jul 2018

Europe -DG Health and Food Safety

10-7-2018

Hirobriz Breezhaler (Novartis Europharm Limited)

Hirobriz Breezhaler (Novartis Europharm Limited)

Hirobriz Breezhaler (Active substance: indacaterol) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)4486 of Tue, 10 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/1211/T/47

Europe -DG Health and Food Safety

10-7-2018

Puregon (Merck Sharp and Dohme B.V.)

Puregon (Merck Sharp and Dohme B.V.)

Puregon (Active substance: follitropin beta) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)4479 of Tue, 10 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/86/T/97

Europe -DG Health and Food Safety

10-7-2018

Ammonaps (Swedish Orphan Biovitrum International AB)

Ammonaps (Swedish Orphan Biovitrum International AB)

Ammonaps (Active substance: Sodium phenylbutyrate) - Centralised - Yearly update - Commission Decision (2018)4483 of Tue, 10 Jul 2018

Europe -DG Health and Food Safety

10-7-2018

Visudyne (Novartis Europharm Limited)

Visudyne (Novartis Europharm Limited)

Visudyne (Active substance: verteporfin) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)4484 of Tue, 10 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/305/T/96

Europe -DG Health and Food Safety

4-7-2018

Tecentriq (Roche Registration GmbH)

Tecentriq (Roche Registration GmbH)

Tecentriq (Active substance: atezolizumab) - Centralised - 2-Monthly update - Commission Decision (2018)4336 of Wed, 04 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4143/II/10

Europe -DG Health and Food Safety

27-6-2018

EU/3/11/849 (Merck Sharp and Dohme B.V.)

EU/3/11/849 (Merck Sharp and Dohme B.V.)

EU/3/11/849 (Active substance: (S)-{8-fluoro-2-2[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)-phenyl]-3,4-dihydro-4-quinazolinyl} acetic acid) - Transfer of orphan designation - Commission Decision (2018)4102 of Wed, 27 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/090/10/T/02

Europe -DG Health and Food Safety

12-6-2018

EU/3/10/811 (Celgene Europe B.V.)

EU/3/10/811 (Celgene Europe B.V.)

EU/3/10/811 (Active substance: N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate) - Transfer of orphan designation - Commission Decision (2018)3809 of Tue, 12 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/092/10/T/03

Europe -DG Health and Food Safety

12-6-2018

EU/3/10/810 (Celgene Europe B.V.)

EU/3/10/810 (Celgene Europe B.V.)

EU/3/10/810 (Active substance: N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate) - Transfer of orphan designation - Commission Decision (2018)3808 of Tue, 12 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/084/10/T/03

Europe -DG Health and Food Safety

12-6-2018

EU/3/10/794 (Celgene Europe B.V.)

EU/3/10/794 (Celgene Europe B.V.)

EU/3/10/794 (Active substance: N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate) - Transfer of orphan designation - Commission Decision (2018)3803 of Tue, 12 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/069/10/T/03

Europe -DG Health and Food Safety

12-6-2018

EU/3/11/888 (Gilead Sciences Ireland UC)

EU/3/11/888 (Gilead Sciences Ireland UC)

EU/3/11/888 (Active substance: N-(cyanomethyl)-4-(2-{[4-(morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)benzamide, dihydrochloride salt) - Transfer of orphan designation - Commission Decision (2018)3802 of Tue, 12 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/152/10/T/03

Europe -DG Health and Food Safety

4-6-2018

Alecensa (Roche Registration GmbH)

Alecensa (Roche Registration GmbH)

Alecensa (Active substance: alectinib) - Centralised - 2-Monthly update - Commission Decision (2018)3621 of Mon, 04 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4164/II/10

Europe -DG Health and Food Safety

29-5-2018

EU/3/10/826 (Eurocept International B.V.)

EU/3/10/826 (Eurocept International B.V.)

EU/3/10/826 (Active substance: Para-aminosalicylic acid) - Transfer of orphan designation - Commission Decision (2018)3396 of Tue, 29 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/072/10/T/02

Europe -DG Health and Food Safety

29-5-2018

EU/3/11/857 (Alnylam Netherlands B.V.)

EU/3/11/857 (Alnylam Netherlands B.V.)

EU/3/11/857 (Active substance: Synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA) - Transfer of orphan designation - Commission Decision (2018)3398 of Tue, 29 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/142/10/T/02

Europe -DG Health and Food Safety

22-5-2018

Pls RT: 10 Ways to Keep Athletes Safe While in the Sun: AVOID THE SUN BETWEEN 10 AM-4 PM when UV rays are strongest! Don't forget: May 25 is #DontFryDay  https://loom.ly/Gbg7XBw  #skincancerpic.twitter.com/mNsFqKTfFk

Pls RT: 10 Ways to Keep Athletes Safe While in the Sun: AVOID THE SUN BETWEEN 10 AM-4 PM when UV rays are strongest! Don't forget: May 25 is #DontFryDay https://loom.ly/Gbg7XBw  #skincancerpic.twitter.com/mNsFqKTfFk

Pls RT: 10 Ways to Keep Athletes Safe While in the Sun: AVOID THE SUN BETWEEN 10 AM-4 PM when UV rays are strongest! Don't forget: May 25 is #DontFryDay https://loom.ly/Gbg7XBw  #skincancer pic.twitter.com/mNsFqKTfFk

FDA - U.S. Food and Drug Administration

21-5-2018

Pls RT: 10 Ways to Keep Athletes Safe While in the Sun: WEAR HATS, SUNGLASSES, AND VISORS. Don't forget: May 25 is #DontFryDay  https://loom.ly/Gbg7XBw  #skincancerpic.twitter.com/WAPabvM811

Pls RT: 10 Ways to Keep Athletes Safe While in the Sun: WEAR HATS, SUNGLASSES, AND VISORS. Don't forget: May 25 is #DontFryDay https://loom.ly/Gbg7XBw  #skincancerpic.twitter.com/WAPabvM811

Pls RT: 10 Ways to Keep Athletes Safe While in the Sun: WEAR HATS, SUNGLASSES, AND VISORS. Don't forget: May 25 is #DontFryDay https://loom.ly/Gbg7XBw  #skincancer pic.twitter.com/WAPabvM811

FDA - U.S. Food and Drug Administration

21-5-2018

Pls RT: 10 Ways to Keep Athletes Safe While In the Sun: APPLY SUNSCREEN. Don't forget: May 25 is #DontFryDay  https://loom.ly/Gbg7XBw pic.twitter.com/YRV0lVSRkh

Pls RT: 10 Ways to Keep Athletes Safe While In the Sun: APPLY SUNSCREEN. Don't forget: May 25 is #DontFryDay https://loom.ly/Gbg7XBw pic.twitter.com/YRV0lVSRkh

Pls RT: 10 Ways to Keep Athletes Safe While In the Sun: APPLY SUNSCREEN. Don't forget: May 25 is #DontFryDay https://loom.ly/Gbg7XBw  pic.twitter.com/YRV0lVSRkh

FDA - U.S. Food and Drug Administration

21-5-2018

EU/3/07/522 (Best Regulatory Consulting Ltd)

EU/3/07/522 (Best Regulatory Consulting Ltd)

EU/3/07/522 (Active substance: (manganese, dichloro [(4aR, 13aR, 17aR, 21aR)-1, 2, 3, 4, 4a, 5, 6, 12, 13, 13a, 14, 15, 16, 17, 17a, 18, 19, 20, 21, 21a-eicosahydro-11, 7-nitrilo-7H-dibenzo[ b,h] [1,4,7,10] tetraazacycloheptadecine-?N5, ?N13, ?N18, ?N21, ?N22]-)) - Transfer of orphan designation - Commission Decision (2018)3136 of Mon, 21 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/089/07/T/01

Europe -DG Health and Food Safety

21-5-2018

RT this: 10 Ways to Keep Athletes Safe While in the Sun: COVER UP! Wear sun-protective clothing and hats. Don't forget: May 25 is #DontFryDay  https://loom.ly/Gbg7XBw pic.twitter.com/GzY50eEVp9

RT this: 10 Ways to Keep Athletes Safe While in the Sun: COVER UP! Wear sun-protective clothing and hats. Don't forget: May 25 is #DontFryDay https://loom.ly/Gbg7XBw pic.twitter.com/GzY50eEVp9

RT this: 10 Ways to Keep Athletes Safe While in the Sun: COVER UP! Wear sun-protective clothing and hats. Don't forget: May 25 is #DontFryDay https://loom.ly/Gbg7XBw  pic.twitter.com/GzY50eEVp9

FDA - U.S. Food and Drug Administration

18-5-2018

EU/3/10/778 (Chiesi Farmaceutici S.p.A.)

EU/3/10/778 (Chiesi Farmaceutici S.p.A.)

EU/3/10/778 (Active substance: Cysteamine bitartrate (gastroresistant)) - Transfer of orphan designation - Commission Decision (2018)3137 of Fri, 18 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/034/10/T/01

Europe -DG Health and Food Safety

16-5-2018

EU/3/10/765 (Novartis Europharm Limited)

EU/3/10/765 (Novartis Europharm Limited)

EU/3/10/765 (Active substance: Midostaurin) - Transfer of orphan designation - Commission Decision (2018)3039 of Wed, 16 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/016/10/T/01

Europe -DG Health and Food Safety

16-5-2018

EU/3/10/764 (Novartis Europharm Limited)

EU/3/10/764 (Novartis Europharm Limited)

EU/3/10/764 (Active substance: Everolimus) - Transfer of orphan designation - Commission Decision (2018)3038 of Wed, 16 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/010/10/T/01

Europe -DG Health and Food Safety

16-5-2018

EU/3/10/830 (AbbVie Deutschland GmbH and Co. KG)

EU/3/10/830 (AbbVie Deutschland GmbH and Co. KG)

EU/3/10/830 (Active substance: Veliparib) - Transfer of orphan designation - Commission Decision (2018)3021 of Wed, 16 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/110/10/T/02

Europe -DG Health and Food Safety